Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Science of eradication
Products for vulnerable populations
Working with regulators
Information for scientists
Call for proposals
TPPs & TCPs
Project of the year award
Computational chemistry
Global health compound design webinars
R&D challenges
Access
Products & projects
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Product maps
Tool Kits
Inj As tool kit
RAS tool kit
Seasonal Malaria Chemoprevention tool Kit
The road to health impact
Access challenges
Partnering
Our partner network
The PDP model
Socially responsible agreements
Our clinical centre partners
Our donors
Current donors
Past donors
Donate to MMV
Donor stories
Our impact
Achievements
Real life stories
Impact of the global malaria community
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff map
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
MMV's internship programme
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Optimizing artemisinin production
Malaria online course
Newsroom
News & Press Releases
Films
Infographics
Interviews
Image slideshows
Publications
Audio
Events
MMV Open
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
Pathogen Box
About the Pathogen Box
Request the Pathogen Box
Exploiting the Pathogen Box
Pathogen Box research
Supporting information
Terms & conditions
Malaria Box
About the Malaria Box
Malaria Box Research
Supporting information
Terms & conditions
Map of box orders
Follow-up guidelines
Open Source Drug Discovery
MMV Open Team
Contact us
Home
Newsroom
News & Press Releases
News & Press Releases
Filter
Category
All
News story
Press release
Topic
Access & product management
Donors
General
Open source
Partner
R&D
Search Terms
16 found
MMV and DND
i
make 400 compounds available to stimulate research into new drugs for pandemic diseases
29 Jan 2019
First open source malaria publication describes new way to do drug discovery
14 Sep 2016
PLOS Pathogens
publishes the Malaria Box findings
28 Jul 2016
Endemic-Region Challenge Grants of USD 50,000 each available to exploit the Pathogen Box
31 Mar 2016
WHO awards over $1 million to MMV’s ‘Exploiting the Pathogen Box’ project
19 Aug 2015
MMV wins Tim Berners-Lee’s Open Data Innovation Award
10 Jul 2015
MMV awards challenge grants to seven Malaria Box recipients
06 Mar 2015
MMV and partners call for compounds to fill the Pathogen Box
18 Feb 2014
Partners commit to bolstering open source research
27 Nov 2013
MMV partner receives PLOS Accelerating Science Award
23 Oct 2013
Potential new class of antimalarials now open source
10 Sep 2013
Open access initiative reveals drug hits for deadly neglected tropical diseases
13 Nov 2012
MMV and the European Bioinformatics Institute establish one-stop shop for malaria drug data
13 Jul 2012
Sharing the fruits of science to accelerate drug discovery
22 Mar 2012
MMV and SCYNEXIS offer 400 active compounds for neglected disease drug research at no cost
19 Dec 2011
Data from MMV-supported research now in the public domain
20 May 2010
